Latest Healthcare Research Reports

Tag: adult vaccines market share

  • Future Outlook of the Adult Vaccines Market: Growth, Trends, and Emerging Opportunities Explored

    Future Outlook of the Adult Vaccines Market: Growth, Trends, and Emerging Opportunities Explored

    Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

    How has the adult vaccines market size evolved in recent years?

    In the past few years, the adult vaccines market has seen robust growth. The industry is expected to expand from a worth of $22.82 billion in 2024 to $24.49 billion in 2025, with a compound annual growth rate (CAGR) of 7.3%. Factors contributing to this growth in the historic period include an increase in the elderly population, government-backed vaccination initiatives, heightened awareness regarding preventative healthcare, progress in vaccine development and innovation, and public health awareness campaigns.

    What are the predictions for the adult vaccines market size in the coming years?

    There is anticipated robust expansion in the adult vaccines market in the coming years. The market is projected to escalate to $35.22 billion by 2029, with a Compound Annual Growth Rate (CAGR) of 9.5%. This growth during the projected period can be credited to the advent of new infectious diseases, the growing emphasis on immunization databases, the escalating threat of antimicrobial defiance, global initiatives for pandemic readiness, the shift towards tailor-made vaccines, and an augmented focus on maternal vaccination. Major trends during the prediction period encompass the integration of digital health, technological progress in vaccine manufacturing, partnerships between governments and pharmaceutical firms, advancements in vaccine distribution technologies, and the expansion of immunization schemes.

    Get your adult vaccines market report here!

    https://www.thebusinessresearchcompany.com/report/adult-vaccines-global-market-report

    What key factors are fueling the growth of the adult vaccines market?

    The surge in infectious diseases is propelling the growth of the adult vaccine market. Infectious diseases are those that can be passed from one individual to another. Vaccines serve as a highly efficient tool in battling these diseases as they bolster an individual’s immunity against them. For example, the Centers for Disease Control and Prevention, a national public health organization based in the U.S., reported that in the year 2022, tuberculosis cases in the U.S. increased to 8,300 from 7,874 in 2021. The incidence rate of TB in 2022 also experienced a slight rise to 2.5 per 100,000 people as opposed to 2.4 in the previous year. As a result, the escalating frequency of infectious diseases is fueling the expansion of the adult vaccine market.

    How is the global adult vaccines market divided into key segments?

    The adult vaccines market covered in this report is segmented –

    1) By Vaccine Type: Monovalent, Multivalent

    2) By Technology: Live Attenuated Vaccines, Inactivated Viral Or Bacterial Vaccines, Toxoid Vaccines, Recombinant Vaccines, Conjugate Vaccines

    3) By Application: Influenza, DPT, Human Papillomavirus, Zoster, Pneumococcal, Hepatitis

    4) By End Users: Healthcare Firms, Hospitals

    Subsegments:

    1) By Monovalent: Single Antigen Vaccines, Specific Disease Vaccines

    2) By Multivalent: Combination Vaccines, Multi-Antigen Vaccines

    Get your free sample now – explore exclusive market insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=9038&type=smp

    Who are the key firms paving the way for growth in the adult vaccines market?

    Major companies operating in the adult vaccines market include GlaxoSmithKline PLC, Merck & Co, Sanofi Pasteur, Pfizer Inc, Commonwealth Serum Laboratories Limited, Johnson & Johnson, Serum Institute of India, AstraZeneca PLC, Novartis AG, Protein Sciences Corporation, Emergent BioSolutions Inc., Bavarian Nordic A/S, Dynavax Technologies Corporation, Novavax Inc, Medimmune LLC, BioNTech SE, Moderna, Inovio Pharmaceuticals, Sinovac, Valneva Se, Biological E Limited, Panacea Biotec, Shenzhen Kangtai Biological Products, Beijing Tiantan Biological Products, Hualan Biological Engineering, Chengdu Institute of Biological Products, Bharat Biotech International Limited, Takeda Pharmaceutical Company Limited

    Which trends are expected to transform the adult vaccines market?

    In the adult vaccines market, one of the primary trends that’s becoming increasingly popular is product innovation. Leading companies in the market have been rolling out inventive products to maintain their market standing. For example, a biopharma company based in the UK known as GSK, along with IQVIA, a global supplier of advanced analytics, technology solutions and clinical research services from India, unveiled Vaccine Track in August 2022. This data trend platform is aimed at boosting adult vaccination in communities across the country. The platform will consistently supply applicable data about trends so as to bolster initiatives in public health.

    Unlock exclusive market insights – purchase your research report now for a swift delivery!

    https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9038

    What regions are contributing significantly to the growth of the adult vaccines market?

    North America was the largest region in the adult vaccines market in 2024. Asia-Pacific is expected to be the fastest-growing region in the adult vaccines market during the forecast period. The regions covered in the adult vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

    Browse Through More Similar Reports By The Business Research Company:

    Network Engineering Services Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/network-engineering-services-global-market-report

    Power Generators Global Market Report 2023

    https://www.thebusinessresearchcompany.com/report/power-generators-global-market-report

    Software Products Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/software-products-global-market-report

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • The Road Ahead for the Adult Vaccines Market: Key Growth Trends and Opportunities to Watch

    The Road Ahead for the Adult Vaccines Market: Key Growth Trends and Opportunities to Watch

    Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

    What CAGR is Anticipated for the Adult Vaccines Market During the Forecast Period, and Why?

    Over the past few years, the adult vaccines market has experienced robust growth. The market is expected to expand from $22.82 billion in 2024 to $24.49 billion in 2025, with a compound annual growth rate (CAGR) of 7.3%. This growth during the historic period can be ascribed to factors such as the expanding aged population, government-led vaccination initiatives, rising consciousness about preventive healthcare, advancements and innovation in vaccine development, and public health awareness campaigns.

    The market size for adult vaccines is projected to witness robust growth in the coming years, with a forecast to reach $35.22 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 9.5%. This forecast period growth is attributable to factors such as the rise of new infectious diseases, heightened focus on immunization registries, the escalating threat of antimicrobial resistance, global strategies for pandemic readiness, a shift towards individually tailored vaccines, and an increased emphasis on maternal immunization. The anticipated trends during this forecast period encompass the incorporation of digital health, technological progression in vaccine manufacturing, collaborations between government bodies and pharmaceutical firms, advancements in vaccine delivery methods, and broadening immunization initiatives.

    How Are the key drivers Contributing to the Expansion of the adult vaccines Market?

    The rise in contagious illnesses is propelling the expansion of the adult vaccination market. These are illnesses that can easily be transmitted from one person to another. Vaccinations are a potent tool in the fight against these diseases, providing individuals with immunity. For instance, the US-based national public health agency, the Centers for Disease Control and Prevention, reported in March 2023 that the number of tuberculosis cases in the United States rose to 8,300 in 2022, an increase from the 7,874 cases in 2021. The incidence of TB also slightly rose to 2.5 per 100,000 individuals in 2022, compared to the 2.4 in 2021. As a result, the rising prevalence of contagious diseases is a significant driver in the growth of the adult vaccine market.

    Get Your Free Sample of the Global Adult Vaccines Market Report Now!

    https://www.thebusinessresearchcompany.com/sample.aspx?id=9038&type=smp

    Which Companies Are Poised to Shape the Future of the Adult Vaccines Market?

    Major companies operating in the adult vaccines market include:

    • GlaxoSmithKline PLC_x000D_

    • Merck & Co_x000D_

    • Sanofi Pasteur_x000D_

    • Pfizer Inc_x000D_

    • Commonwealth Serum Laboratories Limited_x000D_

    What Are the Latest Innovations and Trends Influencing the Adult Vaccines Market?

    The emergence of product innovations is a primary trend catching on in the adult vaccines market. Mainstream businesses in this market are rolling out novel products to maintain their market stance. For example, in August 2022, GSK, a biopharmaceutical firm located in the UK, and IQVIA, an international provider of superior analytics, technology solutions, and clinical research services based in India, introduced Vaccine Track. This data-driven platform aims to boost adult vaccination within communities across the country. This tool aims to offer up-to-date and applicable information on patterns to prioritize and improve public health initiatives.

    Get Instant Access to the Global Adult Vaccines Market Report with Swift Delivery!

    https://www.thebusinessresearchcompany.com/report/adult-vaccines-global-market-report

    How Are the Key Segments of the Adult Vaccines Market Impacting Its Expansion and Revenue Streams?

    The adult vaccines market covered in this report is segmented –

    1) By Vaccine Type: Monovalent, Multivalent

    2) By Technology: Live Attenuated Vaccines, Inactivated Viral Or Bacterial Vaccines, Toxoid Vaccines, Recombinant Vaccines, Conjugate Vaccines

    3) By Application: Influenza, DPT, Human Papillomavirus, Zoster, Pneumococcal, Hepatitis

    4) By End Users: Healthcare Firms, Hospitals

    Subsegments:

    1) By Monovalent: Single Antigen Vaccines, Specific Disease Vaccines

    2) By Multivalent: Combination Vaccines, Multi-Antigen Vaccines

    What Regions Are Contributing Significantly to the Growth of the Adult Vaccines Market?

    North America was the largest region in the adult vaccines market in 2024. Asia-Pacific is expected to be the fastest-growing region in the adult vaccines market during the forecast period. The regions covered in the adult vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

    What Key Elements Shape the Definition of the Adult Vaccines Market?

    Adult vaccines refer to the vaccines that are used to induce an immune response against a disease causing pathogen in adults. These vaccines are used for preventing and treating diseases. Vaccines lessen the severity of illness in individuals who are more vulnerable, such as those with chronic health conditions or weakened immune systems.

    Browse Through More Similar Reports By The Business Research Company:

    Network Engineering Services Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/network-engineering-services-global-market-report

    Power Generators Global Market Report 2023

    https://www.thebusinessresearchcompany.com/report/power-generators-global-market-report

    Software Products Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/software-products-global-market-report

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • Future Outlook of the Global Adult Vaccines Market 2024-2033: Size and Growth Rate Predictions

    Future Outlook of the Global Adult Vaccines Market 2024-2033: Size and Growth Rate Predictions

    Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

    Adult Vaccines Market: What is the Projected CAGR for 2024-2033?

    There has been a substantial growth in the adult vaccines market size in the past few years. The market is projected to expand from $21.48 billion in 2023 to $23.09 billion in 2024, with a compound annual growth rate (CAGR) of 7.5%. Factors contributing to the growth during the historic period include an increase in the elderly population, government-led vaccination programs, growing recognition of preventive healthcare, advancements and innovation in vaccine development, and public health initiatives.

    Expectations are high for robust expansion in the adult vaccines market in the coming years. The market is projected to burgeon to $32.13 billion by 2028, with a compound annual growth rate (CAGR) of 8.6%. The anticipated surge during the forecast period is linked to factors such as the emergence of fresh infectious threats, a growing emphasis on immunization records, the escalating threat of antimicrobial resistance, worldwide efforts toward pandemic preparedness, a tilt towards personalized vaccines, and a heightened focus on maternal immunization. The forecast period also sees promising trends such as the integration of digital health, technological innovation in vaccine manufacture, strategic collaborations between governmental entities and pharmaceutical firms, advancements in vaccine delivery mechanisms, and the widening scope of immunization programs.

    Claim Your Free Sample of the Global Adult Vaccines Market Report Today!

    https://www.thebusinessresearchcompany.com/sample.aspx?id=9038&type=smp

    What Are the Primary Drivers Supporting the Growth of the adult vaccines Market?

    The growth of the adult vaccine market is fueled by the escalating occurrences of infectious diseases. Infectious diseases, which can be transmitted from one individual to another, pose a crucial health challenge. Vaccines are integral to combating these diseases as they boost immunity against them. For instance, the World Health Organization’s COVID-19 dashboard noted that a staggering 655 million people contracted COVID-19 from its onset in 2019 up until December 2022. This data is provided by the Switzerland-based United Nations public health agency. The World Health Organization’s global tuberculosis report informs us that 1.3 million individuals (excluding those with HIV) succumbed to TB (Tuberculosis) in 2021, a significant increase from 1.2 million in 2019. This escalating trend in infectious diseases has spurred the expansion of the adult vaccine market.

    What Are the Core Segments of the Adult Vaccines Market?

    1) By Vaccine Type: Monovalent, Multivalent

    2) By Technology: Live Attenuated Vaccines, Inactivated Viral or Bacterial Vaccines, Toxoid Vaccines, Recombinant Vaccines, Conjugate Vaccines

    3) By Application: Influenza, DPT, Human Papillomavirus, Zoster, Pneumococcal, Hepatitis

    4) By End Users: Healthcare Firms, Hospitals

    What Trends Are Paving the Way for Change in the Adult Vaccines Market?

    Trend 1:

    The emergence of product innovations is becoming a significant trend in the adult vaccines market. Leading companies in the market are launching innovative products to maintain their market stance. For example, in August 2022, UK-based biopharmaceutical firm, GSK, together with IQVIA, a global provider of advanced analytics, technology solutions, and clinical research services based in India, unveiled Vaccine Track. This is a data trend platform designed to aid the improvements of adult vaccination across various communities nationwide. This tool will offer recurrent and pertinent data on trends to concentrate on, thereby boosting public health initiatives.

    Order Now for Fast Delivery of Your Adult Vaccines Market Report!

    https://www.thebusinessresearchcompany.com/report/adult-vaccines-global-market-report

    Which Regions Are Leading the Charge in Adult Vaccines Market Development?

    North America was the largest region in the adult vaccines market in 2023. Asia-Pacific is expected to be the fastest-growing region in the adult vaccines market during the forecast period. The regions covered in the adult vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

    The Adult Vaccines Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the adult vaccines market, its market share, and analyzes key competitors along with their market positions.

    The Table Of Content For The Adult Vaccines Market Include

    1. Adult Vaccines Market Executive Summary

    2. Adult Vaccines Market Segments

    3. Adult Vaccines Market Size And Template Market Growth Rate

    4. Key Adult Vaccines Market Trends

    5. Major Adult Vaccines Market Drivers

    ……

    25. Key Mergers And Acquisitions In The Adult Vaccines Market

    26. Top Adult Vaccines Companies

    27. Adult Vaccines Market Opportunities And Strategies

    28. Adult Vaccines Market, Conclusions And Recommendations

    29. Appendix

    Learn More About The Business Research Company

    The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • Adult Vaccines Market Forecast 2024: Forecast Market Size, Drivers And Key Segments

    Adult Vaccines Market Forecast 2024: Forecast Market Size, Drivers And Key Segments

    The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

    The adult vaccines market has witnessed robust growth in recent years, with a projected increase from $21.48 billion in 2023 to $23.09 billion in 2024, boasting a compound annual growth rate (CAGR) of 7.5%. This expansion is attributed to several factors, including the aging population, government vaccination programs, and heightened awareness of preventive healthcare. Further, vaccine development, innovation, and public health campaigns have contributed significantly to this growth trajectory.

    Forecasting Strong Momentum
    Looking ahead, the adult vaccines market is poised for continued expansion, reaching an estimated value of $32.13 billion by 2028, with a CAGR of 8.6%. Emerging infectious threats, immunization registries, and the escalating threat of antimicrobial resistance are expected to fuel this growth, alongside global efforts for pandemic preparedness and a shift towards personalized vaccines. Maternal immunization is also gaining traction as a focus area for preventive healthcare.

    Spotlight on Trends
    As the market evolves, several trends are shaping its landscape. The integration of digital health, advancements in vaccine production technologies, and strategic collaborations between governments and pharmaceutical companies are among the key trends driving innovation. Moreover, advancements in vaccine delivery technologies and expanding immunization programs are further propelling the market forward, promising a dynamic future for adult vaccinations.

    Rising Prevalence of Contagious Diseases Drives Growth in Adult Vaccine Market
    Understanding the Dynamics
    The escalating prevalence of contagious diseases is a significant driver of growth in the adult vaccine market. With diseases spreading rapidly from person to person, vaccines play a pivotal role in building immunity and combating infections. The impact of contagious diseases is evident, with staggering figures reflecting the toll of diseases such as COVID-19 and tuberculosis (TB) on global health.

    Market Players and Contributions
    Major companies in the adult vaccines market, including GlaxoSmithKline PLC, Merck & Co, Sanofi Pasteur, Pfizer Inc., and others, are actively engaged in vaccine research, development, and distribution. Their efforts are instrumental in addressing the growing demand for adult vaccines, bolstering preventive healthcare initiatives worldwide.

    View More On The Adult Vaccines Market Report 2024 – https://www.thebusinessresearchcompany.com/report/adult-vaccines-global-market-report

    Strategic Collaborations Drive Innovation in Adult Vaccines
    Strategic Alliances
    Leading companies in the adult vaccines market are forging strategic collaborations to advance vaccine development and commercialization. These partnerships facilitate the pooling of resources, expertise, and capabilities to achieve common goals, such as the development of personalized cancer vaccines.

    Case in Point: Merck & Co., Inc. and Moderna Collaboration
    A notable collaboration between Merck & Co., Inc. and Moderna focuses on the development and commercialization of personalized cancer vaccines. The partnership aims to leverage Moderna’s mRNA-4157/V940, in combination with Merck’s anti-PD-1 therapy, for the treatment of high-risk melanoma patients, marking a significant milestone in cancer immunotherapy.

    GSK Expands Vaccine Portfolio Through Strategic Acquisition
    Strategic Acquisition
    GSK’s acquisition of Affinivax, Inc. in August 2022 underscores the company’s commitment to expanding its vaccine portfolio. Affinivax’s innovative pneumococcal and adult vaccines, based on the Multiple Antigen Presenting System (MAPS) platform technology, complement GSK’s existing offerings, positioning the company for continued growth and innovation.

    Segmentation and Regional Outlook
    Segmentation Overview
    The adult vaccines market is segmented based on vaccine type, technology, application, and end-users, offering a comprehensive view of the market landscape. From monovalent to multivalent vaccines and live attenuated to recombinant vaccines, the market caters to diverse healthcare needs and preferences.

    Regional Dynamics
    North America emerged as the largest region in the adult vaccines market in 2023, with Asia-Pacific poised to witness the fastest growth during the forecast period. These regional dynamics underscore the global nature of vaccine distribution and highlight opportunities for market expansion and innovation.

    In conclusion, the adult vaccines market is experiencing unprecedented growth driven by evolving healthcare needs, technological advancements, and strategic collaborations. As the market continues to evolve, stakeholders must remain agile and proactive in addressing emerging challenges and opportunities, ensuring access to safe, effective, and innovative vaccines for adults worldwide.

     Request A Sample Of The Global Adult Vaccines Market Report 2024:
    https://www.thebusinessresearchcompany.com/sample_request?id=9038&type=smp